NFGH
RETA

Nan Fung Group Holdings’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Nan Fung Group Holdings’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$336K Buy
2022
Q4 		– Sell
2022
Q3 		$208K Hold
2022
Q2 		$251K Hold
2022
Q1 		$271K Hold
2021
Q4 		$218K Hold
2021
Q3 		$832K Hold
2021
Q2 		$1.17M Buy